ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

In Brief: ACS Awards Professorship To Bernstein; HCFA Clears Dana-Farber For Medicare

August 11, 1995

Women’s Health Study To Supplant Need for WHT, Greenwald Says

May 31, 1991

NCI Proposes Three New Grant Programs In Nutrition And Research; DRCCA Board, NCAB Approval Required

November 28, 1980

In Brief: Kennedy To Hold Hearing on Mammography Reimbursement, Waxman On Reauthrization

January 15, 1988

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011